Anti-Pythium insidiosum activity of MSI-78, LL-37, and magainin-2 antimicrobial peptides

Braz J Microbiol. 2022 Mar;53(1):509-512. doi: 10.1007/s42770-022-00678-5. Epub 2022 Jan 11.

Abstract

We investigated the anti-Pythium insidiosum activity of the antimicrobial peptides (AMPs) MSI-78, LL-37, and magainin-2. To detect the minimum inhibitory concentration (MIC), fourteen clinical strains were incubated with the AMPs following the CLSI M38-A2 protocol. All three AMPs showed antimicrobial activity with an MIC range of 20-80 mg/L against all strains. We concluded that the evaluated AMPs have great potential as anti-Pythium insidiosum agents, and their activity deserves to be more explored in further research. Antimicrobial peptides were tested against Pythium insidiosum, a microorganism that causes a difficult-to-treat disease in animals and humans. These peptides have been shown to be able to kill P. insidiosum and may be candidates for use in the treatment of this infection.

Keywords: Antimicrobial peptides; LL-37; MSI-78; Magainin-2; Pythium insidiosum.

MeSH terms

  • Animals
  • Antimicrobial Cationic Peptides
  • Antimicrobial Peptides
  • Humans
  • Magainins
  • Microbial Sensitivity Tests
  • Pythium*

Substances

  • Antimicrobial Cationic Peptides
  • Antimicrobial Peptides
  • Magainins
  • pexiganan